X-12886851-C-T
Variant summary
Our verdict is Benign. Variant got -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2
The NM_016562.4(TLR7):c.1343C>T(p.Ala448Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00416 in 1,208,256 control chromosomes in the GnomAD database, including 24 homozygotes. There are 1,602 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another nucleotide change resulting in same amino acid change has been previously reported as Likely benignin UniProt.
Frequency
Consequence
NM_016562.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -16 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TLR7 | NM_016562.4 | c.1343C>T | p.Ala448Val | missense_variant | 3/3 | ENST00000380659.4 | NP_057646.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TLR7 | ENST00000380659.4 | c.1343C>T | p.Ala448Val | missense_variant | 3/3 | 1 | NM_016562.4 | ENSP00000370034 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00284 AC: 317AN: 111780Hom.: 1 Cov.: 23 AF XY: 0.00209 AC XY: 71AN XY: 33992
GnomAD3 exomes AF: 0.00290 AC: 525AN: 181053Hom.: 3 AF XY: 0.00270 AC XY: 180AN XY: 66687
GnomAD4 exome AF: 0.00429 AC: 4708AN: 1096425Hom.: 23 Cov.: 32 AF XY: 0.00423 AC XY: 1531AN XY: 361869
GnomAD4 genome AF: 0.00283 AC: 317AN: 111831Hom.: 1 Cov.: 23 AF XY: 0.00208 AC XY: 71AN XY: 34053
ClinVar
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | TLR7: BP4, BS1, BS2 - |
TLR7-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jan 04, 2024 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at